Home

About Us

Company Profile Development History Qualifications & Honors Aokace Technology Esmay Technology

Products

Careers

News

Company News Academic Sharing Social Responsibility

Service & Support

Español

中文
English
Русский
Español

Products

Safeguarding Health with Quality

Product Center

Urology Consumables Series

Other Consumables Series

Medical Endoscope Series

Tumor Treatment Series

producto
Product Details

Disposable Circulation Tubing Set for Hyperthermic Intracavitary Chemotherapy Device

Disposable Circulation Tubing Set for Hyperthermic Intracavitary Chemotherapy Device

Seleccione el número de especificaciones

Verifique la información del producto que desea！

Product Details

Product Features

The isolated temperature-sensing module enables stable, accurate, and non-contact temperature monitoring, reducing the risk of healthcare-associated infections.
The embedded heating module enables precise heating while providing protection against thermal injury.
The integrated filtration module combines filtration and fluid collection in a single unit.

Treatment Principles

Hyperthermic Tumor Cell Killing

Heating the perfusate, such as normal saline or chemotherapeutic agents, helps destroy tumor cells.

Mechanical Flushing

Continuous perfusion helps flush away free cancer cells and micrometastatic lesions.

Chemosensitizing Effect

Hyperthermia enhances the penetration and molecular activity of anticancer drugs.

Targeted Chemotherapy

The circulation system enables targeted delivery of chemotherapeutic agents to the heated perfusion area.

Catheter Placement Methods

Minimally invasive laparoscopic catheter placement, surgical catheter placement, and ultrasound-guided catheter placement.

Treatment Modes

Preventive Mode

Radical surgery combined with HIPEC. It is suitable for postoperative patients at high risk of peritoneal metastasis and is intended to help prevent peritoneal recurrence or metastasis.

Therapeutic Mode

Cytoreductive surgery combined with HIPEC. It is suitable for patients with peritoneal malignancies who have achieved satisfactory cytoreduction, with no visible tumor or residual tumor nodules smaller than 0.25 cm.

Conversion Therapy Mode

Cytoreductive surgery combined with HIPEC. It is suitable for patients with extensive intraperitoneal metastases or massive ascites. It helps remove or reduce peritoneal tumor nodules and manage malignant ascites. When combined with effective systemic therapy, tumor reduction may make subsequent curative treatment possible.

Combined Treatment Mode

Systemic therapy combined with HIPEC. It is suitable for patients whose condition has progressed after systemic chemotherapy and who present with ascites. This approach helps control disease progression and reduce or eliminate ascites, with significant therapeutic benefits.

Sin comentarios aún

Siguiente : Hyperthermic Intracavitary Chemotherapy Device